cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
about
Neuroendocrine regulation of inflammationRole of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytesSpecific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitroIn vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.Regulation of asthma-related T-cell cytokines by the cyclic AMP-dependent signalling pathway.Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets.GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells.Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2Mitochondrial Superoxide Signaling Contributes to Norepinephrine-Mediated T-Lymphocyte Cytokine Profiles.Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1.Platelet-derived growth factor is a potent biologic response modifier of T cellsTh0 cells in the thymus: the question of T-helper lineages.Sympathetic modulation of immunity: relevance to disease.Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors.An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signalsMechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma modelT regulatory cells in B-cell malignancy - tumour support or kiss of death?Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.Specific activation of human interleukin-5 depends on de novo synthesis of an AP-1 complex.Sympathetic-mediated activation versus suppression of the immune system: consequences for hypertension.cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients.Differential transcription directed by discrete gamma interferon promoter elements in naive and memory (effector) CD4 T cells and CD8 T cells.Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter.Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3.RelA/p65 is a molecular target for the immunosuppressive action of protein kinase ASeasonal variations in cyclic AMP production by peripheral blood mononuclear cells in allergic asthmatics.How is expression of the interleukin-5 gene regulated?TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis.Exclusive expression of the Gs-linked prostaglandin E2 receptor subtype 4 mRNA in mononuclear Jurkat and KM-3 cells and coexpression of subtype 4 and 2 mRNA in U-937 cells.Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles.Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements.Biological and molecular characteristics of interleukin-5 and its receptor.Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.Beta2-agonist exerts differential effects on the development of cord blood T cells but not on peripheral blood T cells.Bi-directional modulation of T cell-dependent antibody production by prostaglandin E(2).
P2860
Q27001639-C096C3F8-08FD-48A0-B2E0-59BB33527EB1Q28267702-E0D15343-987D-4368-BC7A-167788C6D4B9Q28372008-FF0F2A9F-CEE9-43B7-8637-99B2CB164639Q33617972-CF2B6C79-3CA9-4B5E-9A54-17D35C20B07BQ33712137-9AF1D541-A15D-42E9-AF70-C890D4C19F9FQ33940296-7EADD6D2-5290-4D89-B2A2-49494C5B353BQ34236227-045BFE4F-0426-494F-BC71-610C051FF245Q34237405-3829CE34-734B-42C2-BC76-66CAFFA0166EQ34877563-1E9F0850-D2E5-4CED-A208-3F7E58A4B9E9Q35834668-AACC7B77-2611-475E-A619-3520AC207B0CQ35874125-80356138-DCA4-434F-98A9-6DA10C99638BQ36160552-A68290A1-ED29-4231-A7FD-274DDC82A37AQ36228702-486C9DA4-DCE3-452F-8BB2-711710AA3D07Q36229169-7DD0069D-47F4-4025-9E3F-E6A7ED2D11FAQ36230690-FC775D05-5A83-41F5-9F6E-DDA2CB7B434FQ36539190-75BE3870-9EB8-4738-A391-D434CA230828Q36552147-D9409337-4866-45E7-8347-950BD6544EFEQ36648966-F3745800-4AF7-4271-8565-689E67E5ACC1Q36925011-F472DD45-8BC5-47F6-A85E-E78A34E49AE3Q37111968-6E03C837-0C6C-4750-856E-DCF22077BBEFQ37727843-9FFE21E1-C134-42FA-9773-FAB67743AEC2Q37960166-BBE13F42-2D79-42F2-9B8A-2008ACFD68EDQ38306725-846EF80C-09B7-4A45-A567-DA65BF256D05Q38362442-E386DC25-5EA8-43BF-8501-DFA43BE2A7A6Q38717874-5660771E-BB47-459B-8340-FC8D210783BDQ39534564-792A5F5F-4712-404D-A0CD-C52F5558422BQ40020684-939BE0D1-8351-446C-923D-D012DD47111CQ40412449-AB36A6BC-D06C-4192-B31E-9D5B7F8E27BFQ40701095-91F02637-F90E-49E3-BE4D-F3821A5E8AD7Q40806596-16ACC35E-5EDB-405D-8F8C-8F6E101FE822Q40857737-8CBD5822-1188-4556-A574-4169ECBE9889Q41046436-4E7A0B7B-D5F9-47AD-9287-766F10E88C58Q41078827-88EF21CB-45BF-450A-99F5-3DBCDD644F6FQ41166669-F5F0C274-3D38-450F-9D83-349F01E0A7F9Q41483826-423B214D-074A-48CC-94F1-BB3BDF81424CQ41655847-E7FAB571-3D30-4FBC-8D9B-3FE1B1274E66Q41722186-4F8BF79B-FAF0-4B0E-B5D6-C6F117BE7189Q42942780-189AD1FC-C949-47F7-A29A-3067C8775BCAQ43544127-A36C37A5-60F4-4AD9-8285-F938C3FCE0D7Q43829720-65008627-14CB-4161-945A-546846109AD4
P2860
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
description
1990 nî lūn-bûn
@nan
1990 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
name
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
@ast
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
@en
type
label
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
@ast
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
@en
prefLabel
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
@ast
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
@en
P2860
P356
P1476
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
@en
P2093
E V Rothenberg
P2860
P304
P356
10.1073/PNAS.87.23.9353
P407
P577
1990-12-01T00:00:00Z